Research programme: G protein-coupled receptor modulators - BioXell/TaiGen
Alternative Names: GPCR modulators - BioXell/TaiGenLatest Information Update: 01 Jun 2010
At a glance
- Originator BioXell SpA; TaiGen Biotechnology
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 01 Jun 2010 Development discontinued for Inflammation before 2010
- 20 May 2008 Preclinical development is ongoing
- 02 Dec 2002 Preclinical trials in Inflammation in Italy (unspecified route)